Pegasus provides equine veterinarians with standardized, precision‑engineered platelet‑rich plasma (PRP) therapies that promote true joint healing rather than merely masking pain.
Funding
Funding not disclosed
Founders
Product
Problem
Equine veterinarians often rely on corticosteroid injections that only mask joint pain, risking further injury and complications such as laminitis in metabolically compromised horses. Conventional stall‑side platelet‑rich plasma (PRP) kits produce inconsistent platelet and cell concentrations because blood composition varies between horses and throughout the day, leading to unpredictable therapeutic outcomes.
Solution
Pegasus Orthobiologics delivers standardized, precision‑engineered PRP therapies for horses by measuring each animal’s blood cell counts with a state‑of‑the‑art hematology analyzer. This ensures a defined therapeutic platelet dose with consistently low red and white blood cell levels, while also allowing customization based on individual cytokine profiles (IL‑1Ra, IL‑10, TGF‑β1, TNF‑α). Technicians collect blood on‑site and transport it to a sterile lab for rapid processing, then deliver the quantified PRP syringes directly to the veterinarian’s location, eliminating the need for additional staff, equipment, or training. The approach transforms PRP from a hit‑or‑miss treatment into a reliable, data‑driven orthobiologic that supports true joint healing and reduces inflammation.
Target Audience
Primary customers are equine veterinarians and equine sports medicine practices that treat athletic horses and require reliable, standardized regenerative therapies.
Features
- Hematology analyzer quantifies platelets, red and white cells for every PRP preparation, guaranteeing a therapeutic dose
- Optional cytokine quantification (IL‑1Ra, IL‑10, TGF‑β1, TNF‑α) provides deeper insight for customized treatment plans
- On‑site blood collection by Pegasus technicians with same‑day sterile lab processing and delivery to the veterinary practice
- Standardized PRP composition with minimal red/white blood cells, ensuring consistent efficacy across patients
- Growth factor enrichment (TGF‑β, PDGF, EGF, VEGF, FGF) to stimulate tissue repair, stem‑cell recruitment, and angiogenesis
- Data collection for longitudinal patient monitoring and contribution to equine regenerative medicine research